Home
Sessions
PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
Safety and Efficacy of Concurrent Tyrosine Kinase Inhibitors (TKIs) and Cranial Radiotherapy for HER2-Positive Breast Cancer Brain Metastases: A Retrospective Real-World Study

Sep 28

PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology

2927 - Safety and Efficacy of Concurrent Tyrosine Kinase Inhibitors (TKIs) and Cranial Radiotherapy for HER2-Positive Breast Cancer Brain Metastases: A Retrospective Real-World Study

03:00pm - 04:00pm ET

Presenter(s)

Chaonan Zhang, MD - National Cancer Center/National Clinical Research Center for Cance, Beijing, 65